CL
58
2
GPC
37
-14
PSA
66
3
O
31
3
EXPD
53
-3
LYB
46
-4
WFC
63
3
D
60
5
EMC
53
-3
WU
12
-4
AVY
53
-9
LLY
48
-2
CNX
80
4
CMA
62
-2
KEY
51
-3
TGT
50
-2
PEP
47
-3
CMS
67
3
MS
64
7
HSIC
50
-3
CL
58
2
GPC
37
-14
PSA
66
3
O
31
3
EXPD
53
-3
LYB
46
-4
WFC
63
3
D
60
5
EMC
53
-3
WU
12
-4
AVY
53
-9
LLY
48
-2
CNX
80
4
CMA
62
-2
KEY
51
-3
TGT
50
-2
PEP
47
-3
CMS
67
3
MS
64
7
HSIC
50
-3
Financhill
Back

iShares ESG Aware MSCI Canada ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
57

XESG.TO
iShares ESG Aware MSCI Canada ETF

Last Price:
28.91
Seasonality Move:
2.1%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
57
iShares ESG Aware MSCI Canada ETF (XESG.TO) is a Buy

Is iShares ESG Aware MSCI Canada ETF a Buy, Sell or Hold?

  • The current iShares ESG Aware MSCI Canada ETF [XESG.TO] share price is $28.91. The Score for XESG.TO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • XESG.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

XESG.TO Stock Price Chart

What is iShares ESG Aware MSCI Canada ETF's stock price today?

  • The iShares ESG Aware MSCI Canada ETF share price today is $28.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XESG.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

XESG.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 69.33 Buy
Chaikin Money Flow: 2268 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.68 - 28.46) Buy
Bollinger Bands (100): (26.51 - 27.83) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

XESG.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.55 Buy
20-day SMA: 28.14 Buy
50-day SMA: 27.65 Buy
200-day SMA: 26.48 Buy
8-day EMA: 28.56 Buy
20-day EMA: 28.19 Buy
50-day EMA: 27.72 Buy
200-day EMA: 26.6 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

iShares ESG Aware MSCI Canada ETF Earnings Growth & XESG.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

iShares ESG Aware MSCI Canada ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):